Cooperative effects in the substrate specificity of the complement protease C1s

Biological Chemistry

Volumn 390, Issue 5-6, 2009, Pages 503-507

  Boyd, Sarah E ^a   Kerr, Felicity K ^a   Albrecht, David W ^a   De La Banda, Maria Garcia ^a   Ng, Natasha ^a   Pike, Robert N ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Active site; C1s; Complement; Cooperativity; Protease; Substrate specificity

Indexed keywords

COMPLEMENT PROTEINASE C1S; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; COMBINATORIAL CHEMISTRY; COMPLEMENT ACTIVATION; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FACTORIAL DESIGN; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL;

BINDING SITES; CATALYTIC DOMAIN; COMPLEMENT C1S; FACTOR ANALYSIS, STATISTICAL; PEPTIDE LIBRARY; PEPTIDES; RESEARCH DESIGN; SUBSTRATE SPECIFICITY;

EID: 67649587108     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.064     Document Type: Article

References (14)

1. Box, E.P., Hunter, W.G., and Hunter, J.S. (1978). Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building (New York, USA: Wiley and Sons).
2. Boyd, S.E., Pike, R.N., Rudy, G.B., Whisstock, J.C., and Garcia de la Banda, M. (2005). PoPS: a computational tool for modeling and predicting protease specificity. J. Bioinform. Comput. Biol. 3, 551-585.
3. Gosalia, D.N., Salisbury, C.M., Maly, D.J., Ellman, J.A., and Diamond, S.L. (2005). Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays. Proteomics 5, 1292-1298.
4. Janeway, C., Travers, P., Walport, M., and Shlomchik, M. (2001). Immunobiology: The Immune System in Health and Disease (Edinburgh, UK: Churchill Livingstone), pp. 43-64.
5. Kerr, F.K., O'Brien, G., Quinsey, N.S., Whisstock, J.C., Boyd, S., de la Banda, M.G., Kaiserman, D., Matthews, A.Y., Bird, P.I., and Pike, R.N. (2005). Elucidation of the substrate specificity of the C1s protease of the classical complement pathway. J. Biol. Chem. 280, 39510-39514.
6. Kerr, F.K., Thomas, A.R., Wijeyewickrema, L.C., Whisstock, J.C., Boyd, S.E., Kaiserman, D., Matthews, A.Y., Bird, P.I., Thie-lens, N.M., Rossi, V., and Pike, R.N. (2007). Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor. Mol. Immunol. 45, 670-677.
7. Mahrus, S., Trinidad, J.C., Barkan, D.T., Sali, A., Burlingame, A.L., and Wells, J.A. (2008). Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N-termini. Cell 134, 866-876.
8. Morgan, B.P. and Harris, C.L. (2003). Complement therapeutics; history and current progress. Mol. Immunol. 40, 159-170.
9. Ng, N.M., Pike, R.N., and Boyd, S.E. (2009). Subsite cooperativity in protease specificity. Biol. Chem. 390, 401-407.
10. O'Brien, G., Quinsey, N.S., Whisstock, J.C., and Pike, R.N. (2003). Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates. Biochemistry 42, 14939-14945.
11. Rögnvaldsson, T. and You, L. (2004). Why neural networks should not be used for HIV-1 protease cleavage site prediction. Bioinformatics 22, 1702-1709.
12. Schechter, I. and Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
13. Schilling, O. and Overall, C.M. (2008). Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat. Biotechnol. 26, 685-694.
14. Tyndall, J.D.A., Nall, T., and Fairlie, D.P. (2005). Proteases universally recognize β-strands in their active sites. Chem. Rev. 105, 973-999.